These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23454087)

  • 1. Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism.
    Cotton RB; Shah LP; Poole SD; Ehinger NJ; Brown N; Shelton EL; Slaughter JC; Baldwin HS; Paria BC; Reese J
    J Mol Cell Cardiol; 2013 Jun; 59():86-94. PubMed ID: 23454087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period.
    Reese J; Veldman A; Shah L; Vucovich M; Cotton RB
    Semin Perinatol; 2010 Jun; 34(3):222-30. PubMed ID: 20494739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA.
    Vucovich MM; Cotton RB; Shelton EL; Goettel JA; Ehinger NJ; Poole SD; Brown N; Wynn JL; Paria BC; Slaughter JC; Clark RH; Rojas MA; Reese J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H732-40. PubMed ID: 24993047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of H2-receptor antagonists on airway smooth muscle and on responses mediated by H1- and H2-receptors.
    Koga Y; Iwatsuki N; Hashimoto Y
    Anesthesiology; 1987 Feb; 66(2):181-5. PubMed ID: 2880532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematological adverse effects of histamine H2-receptor antagonists.
    Aymard JP; Aymard B; Netter P; Bannwarth B; Trechot P; Streiff F
    Med Toxicol Adverse Drug Exp; 1988; 3(6):430-48. PubMed ID: 2905759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.
    Chen JX; O'Mara PW; Poole SD; Brown N; Ehinger NJ; Slaughter JC; Paria BC; Aschner JL; Reese J
    Pediatr Res; 2012 Aug; 72(2):122-8. PubMed ID: 22565502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famotidine: a notable lack of drug interactions.
    Humphries TJ
    Scand J Gastroenterol Suppl; 1987; 134():55-60. PubMed ID: 2889260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE-mediated drug fever due to histamine H2-receptor blockers.
    Hiraide A; Yoshioka T; Ohshima S
    Drug Saf; 1990; 5(6):455-7. PubMed ID: 1981005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cimetidine, ranitidine and famotidine on rat hepatic microsomal cytochrome P-450 activities.
    Bast A; Smid K; Timmerman H
    Agents Actions; 1989 Apr; 27(1-2):188-91. PubMed ID: 2568738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
    Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
    Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2013 Oct; 37(8):476-85. PubMed ID: 23857299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine and ranitidine, but not cimetidine, cause severe, disabling headache.
    Hirsch E
    Am J Gastroenterol; 1989 Feb; 84(2):202-3. PubMed ID: 2563629
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic.
    Rendić S
    Croat Med J; 1999 Sep; 40(3):357-67. PubMed ID: 10411963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists.
    Ostro MJ
    Am J Med; 1987 Dec; 83(6A):15-22. PubMed ID: 2892405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.